DHHS NIH NIAID RSC Seals Secure DAIDS RSC Document Collaboration Site Web Site Feedback
Home | About the RSC | Frequently Asked Questions | Contact Information | Useful Links | Web Site Update Log
Broadcast Memos
Tutorials and Tools
Regulatory Information
Protocol Development Information
Human Subjects Protection (HSP)
Protocol Registration
Safety and Pharmacovigilance
Case Report Form
(CRF) Management
Clinical Study
Information Office
Safety and Pharmacovigilance

What does the DAIDS/RSC Safety and Pharmacovigilance team do?

The RSC Safety team receives adverse events reported by sites participating in DAIDS-supported studies, processes the events for review by the DAIDS Medical Officer, and prepares the reports for submission to the Food and Drug Administration (FDA). They work closely with the OPCRO Safety and Pharmacovigilance Team (SPT) to establish internal procedures and develop training on Safety and Adverse Event Reporting to DAIDS for the clinical research sites.

Click on a topic below to view detailed information.

Document Title Search

Search Help
RSC Quick Contacts
Package Inserts
Investigator Brochures
Website Change Form
Latest News & Updates